Alexion in Europe

Alexion established operations in Europe in 2005 to support the introduction of our first treatment. Several key global and regional functions for Alexion are now based in Europe, including our EMEAC headquarters in Zürich, Switzerland, which serves as the backbone of the Company’s European, Middle Eastern, African and Canadian operations and supports our mission to serve a growing number of patients with severe and life-threatening disorders. Our global supply chain, quality and manufacturing operations are based in Ireland, and our European R&D Center is based in Paris, France. In addition, Alexion is serving patients with life-threatening rare diseases in more than 30 European countries.

EMEAC Headquarters

Alexion Pharma GmbH

Giesshübelstrasse 30
8045 Zürich, Switzerland
Ph: +41 44 457 40 00 
Fax: +41 44 457 40 01 


Key European Locations

Global Supply Chain and Operations, Ireland

Since 2013, Alexion’s facility in Blanchardstown, Dublin has served as the Company’s Global Supply Chain and Operations headquarters. The site, which will be home to a large-scale biologics manufacturing facility, is also used to house packaging and testing operations in support of our Global Manufacturing network. Construction of a second biologics manufacturing facility in Athlone, Ireland has also begun, and this will accompany the location’s existing fill-finish facility.

Alexion’s investments in both Athlone and Blanchardstown have created a significant number of local job opportunities, including construction jobs, while the sites are being developed as well as full-time Alexion positions. As we continue to drive forward our mission of serving patients with rare diseases, the expansion of our Irish facilities will be at the forefront of this vital work globally.

Alexion R&D Center, France

In June 2015, Alexion established the Alexion R&D Center, Paris – the first European research hub for severe and rare diseases. The R&D Center aims to advance the understanding of  rare diseases, in addition to facilitating the discovery of life-transforming therapies for patients suffering from these diseases. The Center focuses on state-of-the-art discovery research activities in the fields of cell and molecular biology, genomics, and immunogenicity.

The R&D Center is located at the Imagine Institute, a world-renowned facility that shares our objective of discovering innovative therapies for patients with rare diseases. As we expand our research presence in France, Alexion also plans to pursue additional collaborations with other leading hospitals and research centers throughout Europe.

Visit our global site to learn more about our current research and development programs.